Navigation Links
Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
Date:8/12/2008

nomodulators, particularly Diamyd Medical's DiamydT and DeveloGen/Andromeda Biotech's DiaPep-277, will drive growth in the Type 1 diabetes market. Through 2017, sales of DiamydT and DiaPep-277 will reach $45 million.

"Experts that we interviewed unanimously agree that the treatment of type 1 diabetes is characterized by a high level of unmet need for therapies that can halt the destruction of insulin-producing pancreatic-beta cells," said Caroline Gates, analyst at Decision Resources. "Immunomodulators have the potential to preserve beta-cell function, but their use will be hampered by long-term safety concerns, high prices and by the small number of eligible patients who would benefit from these agents."

About Decision Resources

Decision Resources (http://www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE Decision Resources, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
2. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
3. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
4. Treatment Corrects Severe Insulin Imbalance in Animal Studies
5. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
6. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
7. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
8. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
9. Use of Mealtime SYMLIN(R) Compared to Rapid-Acting Insulin for Diabetes Therapy Intensification in Patients With Type 2 Diabetes Using Basal Insulin
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 /CNW Telbec/ - ... Research-Based Pharmaceutical Companies (Rx&D), welcomes the 2015-2016 Quebec ... a working group on the biopharmaceutical industry. However, the ... budget. "We commend the government,s intent to ... announcement of measures to promote Quebec,s ...
(Date:3/27/2015)... Texas , March 27, 2015 The Temple ... in April to a 5,000-square-foot building at 1802 South First ... geographic area designated by the City of Temple ... Scott & White and the Central Texas Veterans Health Care ... and laboratory space to early stage biotechnology and life science ...
(Date:3/27/2015)... March 27, 2015 Zimmer Holdings, Inc. (NYSE and ... system for trauma patients. Available in both ... ® External Fixation System from Zimmer is a modular ...   The XtraFix System allows surgeons to ... external fixation process, resulting in saved time, costs and overall ...
Breaking Medicine Technology:Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 2Quebec 2015-2016 Budget: Rx&D welcomes fiscal discipline and biopharma working group, but the decrease in government spending on medicines is questioned 3Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Zimmer Debuts New Modular External Fixation System 2Zimmer Debuts New Modular External Fixation System 3
... SOMERSET, N.J., Jan. 30 Alfacell Corporation,(Nasdaq: ACEL ... occurred in the Phase IIIb clinical trial of its ... malignant,mesothelioma. Enrollment in the ONCONASE Phase IIIb clinical trial ... patients were enrolled in the,trial., In accordance with ...
... Breast ... Cancer Patients, EVERGREEN PARK, ... Centers in Evergreen Park, Illinois, near Chicago,( http://www.PursuingPainFreeCancer.org/breastcancer ), has announced ... for the,treatment of early stage breast cancer. The study involves the ...
Cached Medicine Technology:Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program 2Breast Cancer Treatment Is Reduced to One Week 2
(Date:3/27/2015)... While deep learning was the topic of many conversations ... the CEO of one start-up spoke passionately about using fast ... beyond the generally-agreed ceiling of 120 years. , Insilico Medicine, ... 12 companies recognized as the hottest GPU-powered startups in the ... Emerging Companies Summit have business models focused on self-driving ...
(Date:3/27/2015)... KING OF PRUSSIA, PA and LONDON, UK (PRWEB) March ... and current President of DrugDev SiteStart Melissa (Liss) Easy ... Under 40. , The 40 Under 40 list ... of age for their professional accomplishments and community involvement. ... and profiled in a special supplement of the Philadelphia ...
(Date:3/27/2015)... The report “CountryFocus: Healthcare, Regulatory and ... information on and analysis of the healthcare, regulatory and ... US in 2013 amounted to 316.1 million, having grown ... from 2008. The country’s increasingly elderly population and corresponding ... to boost the growth of the pharmaceutical market, which ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global MEMS pressure ... MEMS based ultra-miniature pressure sensor designed especially for the ... 220um x 75um provides ample space for 1-French catheter ... industry leading in vivo drift performance of 2 ... pressure range from 0 to 1,100 mmHg absolute. ...
(Date:3/27/2015)... Bellevue, WA (PRWEB) March 27, 2015 ... it can be hard to know where to begin. ... an experienced Seattle trucking accident attorney, offers accident victims ... financial, and legal assistance to ensure their personal injury ... eBook begins by describing the first actions that should ...
Breaking Medicine News(10 mins):Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2
... , KENILWORTH, N.J., Aug. 11 ... an agreement with Orchid Chemicals & Pharmaceuticals Ltd. and Orgenus ... formulations of CLARINEX(R) (desloratadine). , , ... filed and consolidated since 2006 in the U.S. District Court ...
... , Survey seeks feedback from public to help ... CHICAGO, Aug. 11 Participate in the American Dental Association (ADA) ... and become eligible to win a $150 Amazon.com gift certificate and, at the ... ADA.org provides news and information on hundreds of dental topics, ranging from ...
... , MOUNTAIN VIEW, Calif., Aug. 11 VIVUS, ... and commercialization of novel therapeutic products, today reported its financial results for the ... Second Quarter Results , , Net loss ... as compared to net income of $3.6 million, or $0.06 per share, for ...
... , , VERNON HILLS, ... provider of vascular access management services, today announced the launch ... integrated network for physicians to act as one to deliver ... new program has the potential to ultimately save money for ...
... , , SAN BERNARDINO, Calif., Aug. 11 ... food junkies, the all new comic book superhero, Super Nutricia, created by Inland ... children. This is the first ever female superhero from IEHP,s squad of masked ... (Photo: http://www.newscom.com/cgi-bin/prnh/2 0 090811/DC6 0 ...
... newborns experiencing a fatal lack of oxygen, study finds , ... there,s been a nearly 40 percent drop in the risk ... infants in Scotland, new research has found. , The major ... of deaths caused by a lack of oxygen for the ...
Cached Medicine News:Health News:Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R) 2Health News:Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R) 3Health News:American Dental Association Web Survey Offers Chance at $150 Gift Certificate 2Health News:VIVUS Reports Second Quarter 2009 Financial Results 2Health News:VIVUS Reports Second Quarter 2009 Financial Results 3Health News:VIVUS Reports Second Quarter 2009 Financial Results 4Health News:VIVUS Reports Second Quarter 2009 Financial Results 5Health News:VIVUS Reports Second Quarter 2009 Financial Results 6Health News:VIVUS Reports Second Quarter 2009 Financial Results 7Health News:Lifeline Vascular Access Launches New Platform for Physicians to Share Best Practices and Improve Vascular Access Care 2Health News:Introducing All-New IEHP Superhero to Battle Childhood Obesity 2Health News:Introducing All-New IEHP Superhero to Battle Childhood Obesity 3Health News:Delivery-Related Infant Deaths Decline in Scotland 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: